Skip to main content
. 2018 Nov 29;9:720. doi: 10.3389/fendo.2018.00720

Table 3.

Incidence and hazard ratios of gallbladder stone disease measured by age, sex, and comorbidity in type 1 diabetes or type 2 diabetes cohort compared with the corresponding control cohort.

Type 1 diabetes Type 2 diabetes
No (N = 28,060) Yes (N = 7,015) No (N = 51,689) Yes (N = 51,689)
Variables Event Rate# Event Rate# Adjusted HR (95% CI) Event Rate# Event Rate# Adjusted HR (95% CI)
AGE, YEARS
≤ 20 15 1.88 3 1.12 0.42 (0.09, 1.96)
21–40 119 11.7 14 7.30 0.39 (0.19, 0.81)* 31 9.86 89 28.2 2.82 (1.75, 4.57)***
41–60 416 25.0 611 37.1 1.69 (1.46, 1.96)***
61–80 545 44.9 713 60.5 1.44 (1.28, 1.63)***
> 80 52 63.0 53 65.0 1.08 (0.73, 1.61)
SEX
Women 80 8.40 11 4.57 0.46 (0.19, 1.08) 877 39.8 1189 56.3 1.53 (1.35, 1.73)***
Men 54 6.27 6 2.74 0.46 (0.16, 1.27) 734 31.5 1060 47.2 1.56 (1.38, 1.78)***
COMORBIDITY§
No 81 5.56 2 0.96 0.33 (0.08, 1.34) 296 22.3 130 61.6 2.72 (2.21, 3.34)***
Yes 53 14.9 15 5.96 0.56 (0.30, 1.04) 748 38.4 1336 44.4 1.24 (1.13, 1.36)***

Rate#, incidence rate, per 10,000 person-years; Crude HR, relative hazard ratio; 95% CI, 95% confidence interval. Adjusted HR: multivariate analysis including age, sex, hypertension, hyperlipidemia, cirrhosis, stroke, coronary artery disease (CAD), chronic kidney diseases, alcohol-related illness, obesity, and number of parity; Comorbidity§: Patients with any one of the comorbidities (including hypertension, hyperlipidemia, cirrhosis, stroke, CAD, chronic kidney diseases, and alcohol-related illness) were classified as the comorbidity group.

*

P < 0.05;

***

P < 0.001.